InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: None

Wednesday, 10/15/2014 10:57:09 AM

Wednesday, October 15, 2014 10:57:09 AM

Post# of 345969
Well, good morning Ebola.
You guys have been busy on here. I am catching up!

Nice surprise PR but I stay with this.

PPS wise this will not drive us above 2$ today but PR/CC/Q&A tomorrow may.

I normally would not expect a mentioning on CNBC for this, but giving the DOW falling as a block, as is the biotech index, and PPHM being up 15% (and all the news-shorters still have to buy-to-close) it might attract attention.

Ebola is in, it is the topic at hand and this PR is written in direct language leaving no doubts, no "we expect...promising...ect" but "strong binding". Add to that that Bavi is proven SAFE on Humans and that the guy that survived on ZMAb also got transfusions, while the two others on ZMab alone died, it may be that that cocktail could need some Bavi.

So since GSK drives that somewhat and because I would not be surprised that one of those 24+ collaborations is GSK for it's anti-YXZ (AMP-224), contacts could be established quickly. Then let the others do the rest and just deliver Bavi for a price.

Anyway, I don't count on all that. SUNRISE is my main focus and all good that happens before it I'll gladly take it as a bonus. The higher the PPS at the moment SUNRISE news breaks the higher the PPS leverage will be in raw cash for all those that are already in today.

Enjoy your day I am going to have an elaborated breakfast and then see where there is an In & Out Burger for lunch yummy!

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News